Author:
Tuyaerts Sandra,Aerts Joeri L.,Corthals Jurgen,Neyns Bart,Heirman Carlo,Breckpot Karine,Thielemans Kris,Bonehill Aude
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference206 articles.
1. Adams M, Navabi H, Jasani B, Man S, Fiander A, Evans AS, Donninger C, Mason M (2003) Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Vaccine 21:787–790
2. Adamson L, Palmborg A, Svensson A, Lundqvist A, Hansson M, Kiessling R, Masucci G, Mellstedt H, Pisa P (2004) Development of a technology platform for large-scale clinical grade production of DC. Cytotherapy 6:363–371
3. Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A, Thielemans K, Breckpot K (2007) CD83 expression on dendritic cells and T cells: Correlation with effective immune responses. Eur J Immunol 37:686–695
4. Alejandro Lopez J, Crosbie G, Kelly C, McGee AM, Williams K, Vuckovic S, Schuyler R, Rodwell R, Wright SJ, Taylor K, Hart DN (2002) Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy. J Immunol Methods 267:199–212
5. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6:1755–1766
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献